{"name": "BioSante Pharmaceuticals",
 "permalink": "biosante-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/biosante-pharmaceuticals",
 "homepage_url": "http://www.biosantepharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "pdonenberg@biosantepharma.com",
 "phone_number": "(847) 478-0500",
 "description": "",
 "created_at": "Wed Jul 21 02:45:54 UTC 2010",
 "updated_at": "Wed Jul 21 02:46:39 UTC 2010",
 "overview": "\u003Cp\u003EBioSante Pharmaceuticals, Inc. (BioSante) is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company\u00e2\u20ac\u2122s products for female sexual health, menopause, contraception and male hypogonadism include LibiGel, a once daily transdermal testosterone gel in Phase III clinical development under a special protocol assessment (SPA) for the treatment of female sexual dysfunction (FSD); Elestrin, a once daily transdermal estradiol (estrogen) gel indicated for the treatment of moderate-to-severe vasomotor symptoms; The Pill-Plus (triple component contraceptive), a once daily use of various combinations of estrogens, progestogens and androgens in development for the treatment of female sexual dysfunction (FSD) in women using oral or transdermal contraceptives, and Bio-T-Gel, a once daily transdermal testosterone gel in development for the treatment of hypogonadism, or testosterone deficiency, in men. \u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Stephen",
      "last_name": "M. Simes",
      "permalink": "stephen-m-simes",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Phillip",
      "last_name": "B. Donenberg",
      "permalink": "phillip-b-donenberg",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$18M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.biosantepharma.com/News-Releases.php?ID=030410",
    "source_description": "BioSante Pharmaceuticals to Raise $18 Million in Registered Direct Offering",
    "raised_amount": 18000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Great Point Partners",
         "permalink": "great-point-partners",
         "image":
          {"available_sizes":
            [[[150,
               34],
              "assets/images/resized/0005/3085/53085v1-max-150x150.jpg"],
             [[250,
               58],
              "assets/images/resized/0005/3085/53085v1-max-250x250.jpg"],
             [[296,
               69],
              "assets/images/resized/0005/3085/53085v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Deerfield Management",
         "permalink": "deerfield-management",
         "image": null},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "111 Barclay Boulevard",
    "address2": "",
    "zip_code": "60069",
    "city": "Lincolnshire",
    "state_code": "IL",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:BPAX"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}